CBP-CON-00172
Active
Federal
TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.
Awarded by National Blood Authority
National Blood Authority contracted TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD. for AU$30,209,374 to supply imported plasma and recombinant products from September 2022 to September 2027 under limited tender procurement. The contract has one amendment.
$30.2M
Contract Value
Contract Details
- Reference
- CN3924657
- Jurisdiction
- Federal
- Financial Year
- FY27
- Category
- Drugs and Pharmaceutical(UNSPSC: 51000000)
Description
Imported Plasma and Recombinant Products
Key Dates
- Publish Date
- 16 July 2026
- Effective Date
- 30 Sept 2022
- End Date
- 29 Sept 2027
Published fields
- Procurement method
- Limited tender
- Location
- Not published in this source
Supplier
TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.
- ABN
- 71 095 610 870
Agency
National Blood Authority
- ABN
- 87 361 602 478
Contract History
This contract has been amended 1 time.
Original Contract
Published 2 Nov 2022
$11.8M
Amendment A1
Current
Published 16 July 2026
$30.2M